Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 197,668 | 85,551 | 39,084 | 15,689 | 14,562 |
| Cost of Goods | 77,440 | 54,772 | 32,139 | 16,739 | 12,276 |
| Gross Profit | 120,228 | 30,779 | 6,945 | -1,050 | 2,286 |
| Operating Expenses | 125,833 | 84,840 | 56,382 | 38,790 | 25,271 |
| Operating Income | -5,165 | -53,289 | -49,298 | -39,101 | -22,709 |
| Interest Expense | 8,278 | 7,253 | 1,807 | 4,780 | 3,959 |
| Other Income | -100 | -3,809 | -1,176 | 553 | -481 |
| Pre-tax Income | -13,543 | -64,351 | -52,281 | -43,328 | -27,149 |
| Income Tax | 173 | -442 | N/A | N/A | N/A |
| Net Income Continuous | -13,716 | -63,909 | -52,281 | -43,328 | -27,149 |
| Net Income | $-13,716 | $-63,909 | $-52,281 | $-43,328 | $-27,149 |
| EPS Basic Total Ops | -0.39 | -1.93 | -1.72 | -2.64 | -47.29 |
| EPS Basic Continuous Ops | -0.39 | -1.93 | -1.72 | -2.64 | -47.29 |
| EPS Diluted Total Ops | -0.39 | -1.93 | -1.72 | -2.64 | -47.29 |
| EPS Diluted Continuous Ops | -0.39 | -1.93 | -1.72 | -2.64 | -47.29 |
| EBITDA(a) | $9,496 | $-43,124 | $-43,058 | $-33,228 | $-18,641 |